Nokia


HEALTH EDLP

13/05/22 -"15 days ago, we were intrigued by the extent of the collapse in the Health sector (ex Pharmas) even though we had been consistently pointing to the sector's ridiculously high multiples over the last ..."

Pages
48
Language
English
Published on
13/05/22
You may also be interested by these reports :
02/11/26
Over the week to 30-10-2026, European equities had a positive week with the Stoxx600 gaining 1.7%, despite a difficult Friday (-0.4%). Corporate ...

28/10/26
Logitech navigated recent supplier turmoil with remarkable resilience this quarter. Strong momentum across the Americas, premium peripherals, and ...

22/10/26
Nokia delivered strong Q3 results, with sales up 9% and a comparable operating margin expanding 220bp to 11.7%, driven by accelerating AI and cloud ...

22/10/26
Whether or not AI spending is a bubble, it is already big enough to move US GDP. Railways, routers and Spanish rebar suggest the real question is ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO